• IGFBP2–THBS1 Axis in Growth Hormone Therapy

  2026-08-31

  The reference study identifies an IGFBP2–THBS1 regulatory axis that links growth hormone treatment to IGF-1 signaling, chondrocyte proliferation, and hypertrophic differentiation in idiopathic short stature research. Its combination of patient plasma data with gain- and loss-of-function experiments provides a mechanistic framework for interpreting variable responses to somatotropin, while leaving important clinical and in vivo questions unresolved.

• 3D Organoid–Fibroblast Models of PDAC Chemoresistance

  2026-08-30

  Schuth et al. developed a patient-matched three-dimensional co-culture model that combines pancreatic ductal adenocarcinoma organoids with cancer-associated fibroblasts to measure stroma-dependent drug resistance. The study shows that fibroblast interactions increase organoid proliferation, reduce chemotherapy-induced cell death, and promote transcriptional programs consistent with epithelial-to-mesenchymal transition, offering a more biologically informative platform for personalized drug profiling.

• Biotin-16-UTP for RNA-Protein Interaction Assays

  2026-08-29

  Biotin-16-UTP converts an in vitro transcription template into an affinity-handle-bearing RNA for detection, purification, and RNA-protein interaction studies. This guide connects practical labeling workflows with the LINC02870–EIF4G1–SNAIL mechanism reported in hepatocellular carcinoma research, while emphasizing controls, label-density optimization, and troubleshooting.

• (S)-Mephenytoin for CYP2C19 Organoid Assays

  2026-08-28

  Use (S)-Mephenytoin as a mechanism-linked CYP2C19 challenge in hiPSC-derived intestinal organoids, connecting epithelial absorption, transporter activity, and oxidative drug metabolism. This workflow combines a defined enzyme benchmark with a human-relevant pharmacokinetic model while clearly separating validated findings from assay-development recommendations.

• L-Threonine Workflows for Metabolic and ALP Assays

  2026-08-28

  L-Threonine provides a controllable nutrient input for cell culture optimization, metabolic profiling, and nutritional intervention studies, while metal-free carbon-dot nanozymes offer a separate, sensitive route for alkaline phosphatase measurement. This practical guide connects the workflows without overstating their mechanistic relationship and emphasizes preparation, controls, quantitative readouts, and troubleshooting.

• Baicalin Reactivates Adult Ocular Dominance Plasticity

  2026-08-27

  A 2026 NeuroImage study reports that Baicalin reactivated ocular dominance plasticity and restored visual acuity in adult mice with amblyopia when combined with reverse suturing. Imaging, electrophysiology, and pharmacological blockade indicate that reduced GABAergic inhibition and perineuronal-net expression may help reopen visual-cortical plasticity.

• Mianserin HCl: Applied Research Workflows

  2026-08-27

  Mianserin HCl gives researchers a practical way to interrogate 5-HT2-mediated signaling, exposure–response relationships, and formulation-dependent cytotoxicity in one experimental framework. This workflow-focused guide covers assay setup, β-cyclodextrin comparisons, antipathogenic model design, and troubleshooting for reproducible results.

• Arsenic Neurotoxicity, BBB Disruption, and MMP-2/-9

  2026-08-26

  This study connects sodium arsenite-induced cognitive impairment in male mice with MMP-2/MMP-9-associated blood–brain barrier disruption, tight-junction loss, and hippocampal neuronal apoptosis. Its doxycycline hyclate intervention provides pharmacological evidence that MMP activity is a modifiable component of arsenic neurotoxicity, while also highlighting the limits of interpreting a broad MMP inhibitor as a selective mechanistic probe.

• UHRF1, 5-mC, and Osteogenesis in Osteoporosis

  2026-08-26

  The reference study connects UHRF1-dependent DNA 5-methylcytosine remodeling with super-enhancer redistribution and TGM2-regulated autophagic flux in senile osteoporosis. Its multi-omics and functional validation framework identifies an epigenetic mechanism that limits MSC osteogenesis and suggests a testable route for studying age-related bone loss.

• Chloramphenicol A2512: Reliable Lab Workflows

  2026-08-25

  Chloramphenicol (SKU A2512) supports controlled plasmid selection and antimicrobial workflows while requiring careful interpretation in cell viability and cytotoxicity assays. This scenario-based guide connects mechanism, formulation, storage, assay controls, and resistance-gene research to practical laboratory decisions.

• WTAP, m6A, and MYC in Acute Myeloid Leukemia

  2026-08-25

  This study identifies elevated WTAP as an independent poor-risk feature in acute myeloid leukemia and connects WTAP depletion with altered m6A modification of MYC mRNA. Its combination of clinical protein analysis, functional knockdown experiments, transcriptomics, m6A-RIP, and RNA stability testing provides a framework for studying epitranscriptomic control of AML biology.

• RQ3025 and Broad-Spectrum SARS-CoV-2 Vaccination

  2026-08-24

  Lu et al. characterize RQ3025, a mutation-aware bivalent mRNA vaccine designed to broaden neutralization across SARS-CoV-2 variants. Across mouse, hamster, and rat models, the vaccine induced broad antibody responses, supported protection in rats, promoted a Th1-biased cellular response, and showed no evident organ pathology after high-dose administration.

• Lipo3K Transfection Reagent for Kidney Organoids

  2026-08-24

  Lipo3K Transfection Reagent enables practical DNA, siRNA, and co-transfection workflows for kidney models, including challenging organoid-derived cells. This guide translates a DDIT4-centered microplastic nephrotoxicity study into reproducible assay design, optimization, and troubleshooting strategies.

• Batimastat (BB-94) in MMP Assays and Cancer Research

  2026-08-23

  Batimastat (BB-94) is a broad-spectrum hydroxamate MMP inhibitor for dissecting protease-dependent tumor invasion, angiogenesis, and extracellular signaling. This workflow also shows how carefully controlled MMP inhibition can extend neuromuscular-junction studies without confusing exploratory synapse biology with validated cancer-model evidence.

• Sabutoclax: Separating Growth Arrest from Cell Death

  2026-08-22

  Sabutoclax is a pan-Bcl-2 inhibitor whose apparent potency can reflect both proliferation arrest and apoptosis. This guide applies a phenotype-first framework to improve assay interpretation, endpoint selection, and translational decision-making.

8071 records 3/539 page Previous Next 12345 下5页 Last page